Ranjit Akolekar

Active 2008–2026

119
Papers
18,172
Citations
67
h-index
112
i10-index

Citations

Citations per year for Ranjit Akolekar1994: 1 citations2007: 1 citations2008: 7 citations2009: 6 citations2010: 39 citations2011: 67 citations2012: 120 citations2013: 112 citations2014: 89 citations2015: 172 citations2016: 120 citations2017: 163 citations2018: 198 citations2019: 721 citations2020: 808 citations2021: 641 citations2022: 508 citations2023: 405 citations2024: 588 citations2025: 343 citations2026: 7 citations1995–2006: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 814 citing papers, 15.5% of this breakdownUnited Kingdom: 749 citing papers, 14.2% of this breakdownChina: 396 citing papers, 7.5% of this breakdownAustralia: 279 citing papers, 5.3% of this breakdownCanada: 242 citing papers, 4.6% of this breakdownItaly: 221 citing papers, 4.2% of this breakdownNetherlands: 183 citing papers, 3.5% of this breakdownSpain: 175 citing papers, 3.3% of this breakdownGermany: 137 citing papers, 2.6% of this breakdownHong Kong: 121 citing papers, 2.3% of this breakdownFrance: 111 citing papers, 2.1% of this breakdownBelgium: 107 citing papers, 2% of this breakdown
0%15.5%Other 32.9%

Fields

  • Medicine91%
  • Biochemistry, Genetics and Molecular Biology5%
  • Immunology and Microbiology1.1%
  • Neuroscience0.6%
  • Health Professions0.4%
  • Computer Science0.4%
  • Other1.5%

Topics

  • Pregnancy and preeclampsia studies19.5%
  • Prenatal Screening and Diagnostics8.4%
  • Gestational Diabetes Research and Management7.9%
  • Maternal and fetal healthcare6.2%
  • Birth, Development, and Health6%
  • Fetal and Pediatric Neurological Disorders3.5%
  • Other48.5%

Coauthors

All papers

Open in search
  1. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 2,198

  2. Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE

    Authors: , , , , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2018 cited by 380

  3. Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

    Authors: , , , , , , , , , , , , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2018 cited by 430

  4. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation

    Authors: , , , , , , - American Journal of Obstetrics and Gynecology 2015 cited by 626

  5. ASPRE trial: performance of screening for preterm pre‐eclampsia

    Authors: , , , , , , , , , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2017 cited by 459

  6. Competing risks model in screening for preeclampsia by maternal characteristics and medical history

    Authors: , , , , - American Journal of Obstetrics and Gynecology 2015 cited by 420

  7. Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia

    Authors: , , , , , , , , , , , , , , , , - Circulation 2021 cited by 116

  8. Fetal Medicine Foundation fetal and neonatal population weight charts

    Authors: , , , , - Ultrasound in Obstetrics and Gynecology 2018 cited by 350

  9. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus

    Authors: , , , , , , , - New England Journal of Medicine 2016 cited by 389

  10. Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis

    Authors: , , , , - Ultrasound in Obstetrics and Gynecology 2015 cited by 807

  11. Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

    Authors: , , , , - Fetal Diagnosis and Therapy 2012 cited by 601

  12. Maternal and neonatal complications of fetal macrosomia: systematic review and meta‐analysis

    Authors: , , , , , - Ultrasound in Obstetrics and Gynecology 2019 cited by 302

  13. Diagnosis of fetal non‐chromosomal abnormalities on routine ultrasound examination at 11–13 weeks' gestation

    Authors: , , , , , - Ultrasound in Obstetrics and Gynecology 2019 cited by 336

  14. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta‐analysis

    Authors: , , , , - Ultrasound in Obstetrics and Gynecology 2019 cited by 356

  15. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 280

  16. Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

    Authors: , , , , , , , , , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2017 cited by 255

  17. Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysis

    Authors: , , , , - Ultrasound in Obstetrics and Gynecology 2014 cited by 730

  18. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks

    Authors: , , , , - Prenatal Diagnosis 2010 cited by 255

  19. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history

    Authors: , , , , , , , , , , , , , , , - American Journal of Obstetrics and Gynecology 2017 cited by 191

  20. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35–37 weeks’ gestation

    Authors: , , , , - American Journal of Obstetrics and Gynecology 2019 cited by 112

  21. First-Trimester Prediction of Hypertensive Disorders in Pregnancy

    Authors: , , , , - Hypertension 2009 cited by 461

  22. Machine learning-enabled maternal risk assessment for women with pre-eclampsia (the PIERS-ML model): a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jing Li, Kenneth Lim, Sarka Lisonkova, Paula Lott, Jennifer M. Menzies, Alexandra Millman, Lynne Palmer, Beth A. Payne, Ziguang Qu, James A. Russell, Diane Sawchuck, Dorothy Shaw, Douglas K. Still, Ugochinyere Vivian Ukah, Brenda Wagner, Keith R. Walley, Dany Hugo, The late Andrée Gruslin, George Tawagi, Graeme N. Smith, Anne‐Marie Côté, Jean‐Marie Moutquin, Annie Ouellet, Shoo K. Lee, Tao Duan, Jian Zhou, The late Farizah Haniff, Swati Mahajan, Amanda Noovao, Hanna Karjalainend, Alja Kortelainen, Hannele Laivuori, J. Wessel Ganzevoort, Henk Groen, Phillipa M. Kyle, M. Peter Moore, Barbra Pullar, Zulfiqar A Bhutta, Rahat Qureshi, Rozina Sikandar, The late Shereen Z. Bhutta, Garth Cloete, David Hall, The late Erika van Papendorp, D.W. Steyn, Christine Biryabarema, Florence Mirembe, Annettee Nakimuli, John Allotey, Shakila Thangaratinam, K. H. Nicolaides, Olivia Ionescu, Argyro Syngelaki, Michael de Swiet, Laura A. Magee, Peter von Dadelszen, Ranjit Akolekar, James J. Walker, Stephen C. Robson, Fiona Broughton-Pipkin, Pamela Loughna, Manu Vatish, Christopher W.G. Redman, Sarah Barry, Kimberley Kavanagh, Tunde Montgomery-Csobán, Paul Murray, Chris Robertson, Eleni Tsigas, Douglas Woelkers and 5 more - The Lancet Digital Health 2024 cited by 42

  23. Fetal Medicine Foundation reference ranges for umbilical artery and middle cerebral artery pulsatility index and cerebroplacental ratio

    Authors: , , , , , - Ultrasound in Obstetrics and Gynecology 2018 cited by 200

  24. Value of routine ultrasound examination at 35–37 weeks' gestation in diagnosis of fetal abnormalities

    Authors: , , , , - Ultrasound in Obstetrics and Gynecology 2019 cited by 107